Atlas Trials

Ketamine for the Treatment of Refractory Status Epilepticus

Clinical trial NCT07177235 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07177235
Sponsor
Thomas Jefferson University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Refractory Status Epilepticus
Start date
2025-11-01
Primary completion
2027-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.